Dexketoprofen trometamol in the acute treatment of migraine attack: a phase II, randomized, double-blind, crossover, placebo-controlled, dose optimization study

Company Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum porta libero erat. Nullam at ipsum quis felis egestas vulputate nec nec ligula.

January 16, 2014

tony w

The Journal of Pain